Levoleucovorin — 50 mg per 5 mL, Lyophilized powder for solution for injection, 1 vial (5 mL) in 1 box

Levoleucovorin — 50 mg per 5 mL, Lyophilized powder for solution for injection, 1 vial (5 mL) in 1 box

Levoleucovorin is a lyophilized powder for solution for injection for intravenous use. Levoleucovorin for Injection is indicated for: rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. Supplied as 1 vial (5 mL) in 1 box; NDC 0143-9558-01; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Protect from light. Levoleucovorin for Injection is a sterile white to pale yellow lyophilized powder in a single dose vial available as: 50 mg vial – NDC 0143-9558-01 Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].

• Active ingredient or product type: LEVOLEUCOVORIN CALCIUM
• Strength/concentration: 50 mg per 5 mL
• Dosage form and route: Lyophilized powder for solution for injection, Intravenous
• Exact package presentation: 1 vial (5 mL) in 1 box
• NDC/item number: 0143-9558-01
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Protect from light. Levoleucovorin for Injection is a sterile white to pale yellow lyophilized powder in a single dose vial available as: 50 mg vial – NDC 0143-9558-01 Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Hypercalcemia: Due to calcium content, inject no more than 16 mL (160 mg) of levoleucovorin solution intravenously per minute.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.